Different outcomes of telomere-dependent anaphase bridges
- 24 November 2010
- journal article
- Published by Portland Press Ltd. in Biochemical Society Transactions
- Vol. 38 (6) , 1698-1703
Abstract
Chromosomal instability occurs early in the development of cancer and may represent an important step in promoting the multiple genetic changes required for the initiation and/or progression of the disease. Telomere erosion is one of the factors that contribute to chromosome instability through end-to-end chromosome fusions entering BFB (breakage–fusion–bridge) cycles. Uncapped chromosomes with short dysfunctional telomeres represent an initiating substrate for both pre- and post-replicative joining, which leads to unstable chromosome rearrangements prone to bridge at mitotic anaphase. Resolution of chromatin bridge intermediates is likely to contribute greatly to the generation of segmental chromosome amplification events, unbalanced chromosome rearrangements and whole chromosome aneuploidy. Accordingly, telomere-driven instability generates highly unstable genomes that could promote cell immortalization and the acquisition of a tumour phenotype.Keywords
This publication has 41 references indexed in Scilit:
- In the End, its all StructureCurrent Molecular Medicine, 2005
- Senescence and immortalization: role of telomeres and telomeraseCarcinogenesis, 2004
- Telomere Length Abnormalities Occur Early in the Initiation of Epithelial CarcinogenesisClinical Cancer Research, 2004
- A DNA damage checkpoint response in telomere-initiated senescenceNature, 2003
- Telomere dysfunction provokes regional amplification and deletion in cancer genomesCancer Cell, 2002
- Chromosome segregation and cancer: cutting through the mysteryNature Reviews Cancer, 2001
- Telomere Dysfunction Increases Mutation Rate and Genomic InstabilityCell, 2001
- The age of cancerNature, 2000
- Chromosomal breakage-fusion-bridge events cause genetic intratumor heterogeneityProceedings of the National Academy of Sciences, 2000
- Genetic instabilities in human cancersNature, 1998